Literature DB >> 28945729

Bone Health, Pain, and Mobility: Evidence-Based Recommendations for Patients With Multiple Myeloma

Sandra Rome1, Kimberly Noonan2, Page Bertolotti1, Joseph D Tariman3, Teresa Miceli4.   

Abstract

BACKGROUND: About 85% of patients with multiple myeloma develop bone disease. In these patients, lytic bone lesions can cause fractures, poor circulation, blood clots, pain, poor mobility, and decreased quality of life.
.
OBJECTIVES: This article presents consensus statements to guide nurses in the assessment and management of bone disease, pain, and mobility in patients with multiple myeloma at varying points in their disease trajectory.
.
METHODS: Members of the International Myeloma Foundation Nurse Leadership Board reviewed previously provided recommendations, current recommendations based on literature review, and evidence-based grading.
.
FINDINGS: Oncology nurses play a key role in maximizing bone health, minimizing skeletal injury, maximizing pain control, and improving quality of life in patients by enhancing patient mobility and safety. Clinician assessment accompanied by effective interventions reduces patient injury and optimizes functioning in patients with multiple myeloma.

Entities:  

Keywords:  bone health; functional mobility; multiple myeloma; pain

Mesh:

Year:  2017        PMID: 28945729     DOI: 10.1188/17.CJON.S5.47-59

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  2 in total

Review 1.  Mechanisms of bone pain: Progress in research from bench to bedside.

Authors:  Gehua Zhen; Yuhan Fu; Chi Zhang; Neil C Ford; Xiaojun Wu; Qichao Wu; Dong Yan; Xueming Chen; Xu Cao; Yun Guan
Journal:  Bone Res       Date:  2022-06-06       Impact factor: 13.362

2.  A worm gel-based 3D model to elucidate the paracrine interaction between multiple myeloma and mesenchymal stem cells.

Authors:  Renza Spelat; Federico Ferro; Paolo Contessotto; Nicholas J Warren; Grazia Marsico; Steven P Armes; Abhay Pandit
Journal:  Mater Today Bio       Date:  2020-01-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.